Conference abstract · 27 Jul 2015
Conference abstractPublished 20 Feb 2017
Mucosal Immunization via conjunctiva: Where do we stand?
Medical University of Vienna, Austria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The ocular surface is recognized as part of the mucosal immune system as conjunctiva-associated lymphoid tissue (CALT). This lymphoid tissue consists of intraepithelial lymphocytes, sub-epithelial lymphoid follicles (conjunctival follicles) and adjacent lymphatic and blood vessels. Furthermore, together with lacrimal drainage-associated lymphoid tissue (LDALT), CALT forms the eye-associated lymphoid tissue (EALT). All these components have a key role in the protection of the ocular surface by initiating and regulating immune responses. In the context of needle-free delivery approach, the conjunctiva and its underlying CALT, with its possibility to detect antigens, taken up at the ocular surface, present them, and generate specific and nonspecific effector cells, would be an attractive choice for mucosal immunization, particularly against ocular infections. As the conjunctiva and CALT are interconnected with the nasal mucosa via the draining tear duct, antigens would additionally drain to nasal-associated lymphoid tissue (NALT). Actual developments and outlooks for conjunctival immunization will be presented.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 28 Jul 2016
The conjunctiva as a site for investigation of human mucosal immunology in situ elucidating the mechanisms of immune escape in adenovirus induced epidemic keratoconjunctivitis
Conference abstract
Mucosal immunization with an unadjuvanted vaccine that targets S. pneumoniae PspA to human Fc?RI protects against Pneumococcal infection via complement- and Lactoferrin-Mediated Bactericidal Activity
Conference abstract · 20 Feb 2017
Use of corpuscular adjuvants for ocular mucosal immunization as a strategy for vaccine against trachoma
Conference abstract · 20 Feb 2017
The VCG platform facilitates mucosal and systemic vaccine delivery for induction of protective immunity in the female genital tract
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectImmunology & Microbiology
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Talin Barissani-Asenbauer”
